Article | June 15, 2021

Great Size ≠ Great Value: How Smaller Outsourcing Partners Benefit Small And Emerging Biotechs

By Joseph Arcangelo, Sr., inSeption Group

Big business and small business iStock-878980868

Sponsors seeking an outsourcing partner to shepherd their novel drug product through clinical trials all face the same challenge: identifying a partner that combines high quality and expeditious service with an emphasis on cost mitigation. All potential partners — from the largest contract research organization (CRO) to the most niche “boutique” outsourcing operations — will claim the necessary capability to meet your every need.

Some outsourcing organizations tout a low (initial) cost or some application of unique technology. Others point to their past accomplishments or sell their process. The most valuable asset an outsourcing partner can offer is high-quality personnel, each experienced in their current role and passionate about its undertaking. The challenge for sponsors is how to identify partners that can consistently provide such talent across the life of their project, teams of individuals whose expertise is custom-assembled for that project.

The biopharma industry spends tens of billions of dollars annually on contract research and outsourced clinical trial management services. This market is growing and has attracted numerous players, complicating sponsors’ search for a partner whose capability, cost, and process meet their needs. Knowing where to start the search, as well as the best questions to ask when a potential outsourcing partner has been identified, eases this effort considerably.


Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.

Subscribe to Outsourced Pharma X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Outsourced Pharma